|
CA2848965A1
|
|
Bioresorbable drug delivery matrices based on cross-linked polysaccharides, dosage forms designed for delayed/controlled release
|
|
CN101466403A
|
|
Method for delivering a human chorionic gonadotropin (hCG) vaccine for long-acting antibody production
|
|
KR20080016578A
|
|
Bioresorbable polymer matrices and methods of making and using the same
|
|
WO2005069837A2
|
|
Non-aqueous compositions for treatment of orthopedic defects and delivery of bioactive agents
|
|
CA2529503A1
|
|
Drug polymer complexes
|
|
AU2003243608A1
|
|
Resorbable delivery systems for the treatment of cancer
|
|
WO2004000276A1
|
|
Resorbable matrices with coatings for delivery of bioactive compounds
|
|
AU2002322424A1
|
|
Novel methods and formulations for administration of active agents
|
|
US6497901B1
|
|
Resorbable matrices for delivery of bioactive compounds
|
|
US6391336B1
|
|
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
